TESSA FARNHAM: Open Payments
NPI 1386390268 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,973 in 117 payments from 14 companies in 2025. Trend: 2023 $762 · 2024 $944 · 2025 $1,973
Food & beverage: $1,873Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $455 |
| ABBVIE INC. | 18 | $298 |
| UCB, Inc. | 11 | $235 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $228 |
| Novartis Pharmaceuticals Corporation | 13 | $196 |
| PFIZER INC. | 19 | $165 |
| Lilly USA, LLC | 14 | $161 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Botanix SB Inc | 3 | $48 |
| Organon LLC | 1 | $34 |
Products named: TREMFYA, Bimzelx, ILUMYA, SKYRIZI, CIBINQO, COSENTYX, TALTZ, RINVOQ.
Industry payments across NE — which companies pay providers there.
